
HKU Ecologists Lead International Effort to Understand Declining Insect Biodiversity in the Tropics
Professor Louise ASHTON Dr Michael BOYLE A team of ecologists from The University of Hong Kong (HKU) are leading an international initiative to investigate the decline of insect populations in the world’s tropical forests. Insects, the most abundant and diverse group of animals on Earth, are experiencing alarming declines, prompting this research effort. The team’s work has earned them an invitation to lead a review on the topic for Nature Reviews Biodiversity, a new journal from the high-impact Nature Portfolio, showcasing HKU’s status as a global centre of excellence for tropical ecology and conservation. The research was led by Dr Michael BOYLE and Professor Louise ASHTON from the HKU School of Biological Sciences, with contributions from Dr Adam SHARP, Dr Martha LEDGER, Dr Michel DONGMO and Professor Timothy BONEBRAKE from the same school. This collaborative effort spans continents, involving scientists from South America, Asia, Africa, Australia and Europe. It exemplifies how innovative insights into some of the most pressing current issues can arise from global scientific partnerships. Understanding the Status of Tropical Insects in a Changing World Insects play a crucial role in the functioning of ecosystems, but alarmingly they may be facing declines globally. While most of our knowledge comes from studies conducted in Europe, most insect species inhabit in tropical rainforests, where our understanding remains surprisingly limited. In tropical regions, insects face numerous threats including urbanisation, habitat loss and fragmentation, and pollution from agriculture and urban areas. The team notes that insects on tropical islands are particularly vulnerable to invasive species, with many unique species already extinct due to this threat. More broadly, climate change poses a huge threat to insect populations across the tropics, not just through rising temperatures but through disruptions to crucial weather cycles such as El Niño and La Niña. The scientists explain how declining insect biodiversity may have knock-on consequences for ecosystem processes such as carbon cycling, which could impact the Earth globally. Changes in the ecosystem balance could also lead to increased outbreaks of pests and insect-vectored diseases such as dengue and malaria in humans, as well as similar diseases in livestock, affecting global health and reducing food security. The team emphasises that large gaps remain in our understanding due to insufficient data from tropical forests. However, recent advances in artificial intelligence and genetic methods are beginning to address these challenges. ‘Despite the relative lack of data in the tropics, the review highlights many reasons for concern regarding the status of tropical insects,’ said Professor Timothy Bonebrake, one of the key authors of the review. ‘We need more research, and our review points to directions to this end – but we also need to conserve habitats now and implement other conservation interventions to maintain tropical biodiversity.’ Laying the Foundations for Future Research Over the past three years, the team has conducted extensive field research across tropical Australia and Asia, revisiting forests where insect studies were previously undertaken. The ongoing research in Lamington National Park, Australia and Danum Valley Conservation Area, Borneo, involves collecting ants, moths, beetles and butterflies using specialised traps to assess how climate change has re-wired these populations over the last two decades. Similar studies are being carried out in Yunnan, China and Daintree, Australia, including the use of tower cranes to collect insects from the rainforest canopy. The team’s diligent work lays the groundwork for future research at HKU. They plan to study the ecological roles and functions of insect species to understand how changing populations will impact tropical forest ecosystems. They suspect that the important processes provided by beneficial insects, including regulating forest growth through herbivory and nutrient cycling, are dwindling over time. Such analyses have never before been undertaken using such large volumes of data from so many tropical forest locations and over such long-time spans. ‘Most studies of insect declines are from modified landscapes in Europe and North America,’ said Professor Louise Ashton, corresponding author of the review.’ However, most insect biodiversity is in the tropics. Due to a lack of long-term monitoring data, we do not fully understand how insect diversity changes over time. This review and our related projects highlight this issue and bring together new long-term insect data to help understand potential tropical insect declines and their consequences for ecological functioning.’ Click here to view the full paper. Praying mantis (Deroplatys sp.) at Danum Valley Conservation Area, Borneo. (Photo courtesy: Marco Chan) Professor Louise Ashton (front) working in the field of Maliau Basin Conservation Area, Borneo, with Bartosz Majcher. (Photo courtesy: Louise Ashton) Dr Michael Boyle collecting leaf litter insects at Danum Valley Conservation Area, Borneo. (Photo courtesy: Louise Ashton)
NEWS DETAIL

Revolutionising Drug Discovery through AI
Dr Serena YANG Co-founder and CEO AILSI (AI and Life Sciences Institute (HK)) PhD alumna (Chemistry) Artificial Intelligence (AI) is transforming drug discovery, revolutionising how we identify disease-causing genes and proteins, and accelerating drug design at an unprecedented pace. Dr Serena YANG, an alumna of HKU Chemistry, stands at the forefront of AI-driven drug discovery as the co-founder of AILSI (AI and Life Sciences Institute (HK)). Harnessing the power of AI, her company identifies novel drug targets and accelerates the design of new treatments, significantly reducing the time and cost associated with traditional methods. A recent milestone project involved using AI-driven multi-omics analysis to identify a previously undiscovered protein implicated in liver cancer and designing a drug targeting this protein. ‘This project showcases how AI can uncover new biological insights and accelerate drug discovery,’ Dr Yang shares. Believe in the power of belief. While technical skills (the machine) are essential, what truly drives progress is belief (the oil)—belief in your vision, work, and ability to make a difference. From Academia to Industry Talking about the birth of AILSI, Dr Yang recalls ‘My goal has always been to help patients who have no effective therapeutic options and to make drugs more affordable for everyone.’ Driven by her vision to revolutionise the pharmaceutical industry, Dr Yang embarked on a journey from academia to entrepreneurship. This journey culminated in the founding of AILSI, which made drug discovery more efficient and cost-effective. Transitioning from academia—where she built a deep learning model for predicting small molecule properties—to founding AILSI was not without its challenges. ‘Overcoming skepticism from industry stakeholders required continuous communication and demonstrating real-world results,’ she notes. Her persistence and innovative approach paid off, bridging the gap between AI and the pharmaceutical industry. A Vision for AI in Precision Medicine ‘AI-driven drug discovery is set to revolutionise global healthcare by making drug development faster, more cost-effective, and personalised,’ Dr Yang asserts. ‘Our work is about more than just creating new drugs; it's about creating a new paradigm in healthcare.’ Looking ahead, Dr Yang envisions a future where AI is integral to every stage of drug development, unlocking new levels of efficiency and innovation. At AILSI, the commitment to democratising healthcare extends beyond drug discovery to developing AI-powered diagnostic tools. ‘My goal is to bring an AI-designed drug to market and have an AI-powered diagnostic tool approved for clinical use,’ she reveals. Her ambition is to build a strong AI-driven ecosystem that transforms how we develop medicines and diagnose diseases. Advice for Aspiring Innovators The relentless pace of innovation at AILSI is matched by a commitment to ethical considerations and patient-centric approaches. ‘As we push the boundaries of AI in healthcare, we must remain vigilant about the ethical implications and ensure that our advancements benefit all patients equitably,’ Dr Yang notes. Her leadership is a beacon for aspiring scientists and entrepreneurs who seek to navigate the complex landscape of modern healthcare. For those on the cusp of their journeys in science and technology, Dr Yang’s advice resonates deeply: ‘Stay curious, remain persistent, and always be open to learning. The challenges you face today will be the stepping stones to your breakthroughs tomorrow. If you are passionate and persistent, no matter how challenging the journey, you will eventually achieve your goal,’ Dr Yang remarks. ‘In AI-driven drug discovery, this belief is crucial. The field is full of uncertainties. Only with relentless innovation and the courage to challenge the status quo, can we transform how medicine is discovered and bring hope to patients who need it most.’ As we stand on the brink of a new era in medicine, Dr Serena Yang’s story is a powerful reminder that through unwavering dedication and innovative thinking, we can indeed change the world. With the right blend of passion, persistence, and cutting-edge innovation, the future of healthcare is boundless, brimming with limitless possibilities. Academic Foundations as Catalyst for Innovation Dr Yang's academic journey began with a focus on biology and chemistry, driven by a deep-seated curiosity about complex systems. During her lab internship, she encountered the potential of AI when analysing experimental data. ‘I realised how even a simple machine learning algorithm could help make sense of the results. That experience sparked my interest in AI’s potential in life sciences,’ she recalls. This curiosity led her to pursue a PhD in Quantum Chemistry and AI at HKU, where she could work at the intersection of physics, chemistry, and machine learning. ‘The training I received at HKU provided me with a strong foundation in computational modelling, problem-solving, and interdisciplinary research.’ HKU provided Dr Yang with a fertile ground for her burgeoning interests. Its cutting-edge research and interdisciplinary environment allowed her to delve into physics, chemistry, and machine learning. The access to advanced computational resources, world-class faculties, and a dynamic research community enriched her learning experience. ‘The training I received at HKU shaped my approach to tackling real-world scientific challenges,’ she explains.
NEWS DETAIL